JPMorgan downgrades DuPont stock rating on recovery outlook
JPMorgan downgraded DuPont (NYSE:DD) to Neutral from Overweight, lowering its price target to $145 from $172. The stock trades at $132.48, considered undervalued. DuPont reported Q2 2026 earnings, beating estimates with $1.88 EPS and $1.82B revenue. BMO Capital reiterated its Outperform rating, maintaining a $186 price target.
How this was made
The 30-second read
Why it matters
Analyst downgrade introduces fresh downside risk despite recent earnings beat, likely prompting short‑term selling pressure.
Market read
The downgrade provides a new actionable signal for traders, potentially moving DD lower in the pre‑market session.
What to watch
The company's solid Piotroski score and recent inventory recovery could support a rebound if the market overreacts.
Background
JPMorgan lowered its rating on DuPont (DD) to Neutral from Overweight and reduced the price target to $145 from $172, citing a slowdown in short‑cycle inventory recovery.
Ticker impact
JPMorgan downgraded DuPont to Neutral and cut its price target to $145, providing fresh analyst action after the company's Q2 earnings were already public.
downward pressure as the market prices in the lower target and neutral rating
Analyst rating change is a primary catalyst; the new target is 8% below the current price, prompting sell‑side activity.
Market effects
The downgrade may weigh on the broader specialty chemicals sector as peers are re‑evaluated.
US market sentiment could dip slightly in chemicals and industrials.
Limited to investors tracking DuPont and related chemical stocks.
Counterpoint
Some investors may view the downgrade as premature given DuPont's recent earnings beat and strong balance sheet.
Key entities
- companyDuPont
Specialty chemicals maker, ticker DD.
- analystJPMorgan
Equity research firm issuing the downgrade.


